Intellipharmaceutics International 20F 2013 Annual report | IPCIF Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Accession, accreted, adequacy, Apr, AUC, bifurcated, carryforward, clear, clock, coincident, conclusion, construed, contrast, coupon, customarily, Derecognition, discourage, divergence, diversified, draft, dumping, Emerging, exhibit, extracting, fasted, FATCA, foreclosed, formation, formula, GDUFA, host, hydrocodone, incidental, ingesting, interfere, interfering, interval, intranasal, Japanese, Master, Medicaid, misuse, morphine, necessarily, NOL, Nonsubstantive, oxymorphone, Parent, passage, presence, purging, randomized, realistically, recapitalization, reclassified, Regabatin, repay, repossessed, Restore, retard, Roth, sense, ship, shortly, slope, stream, tampering, Task, therefrom, tied, timeline, toxicity, underwritten, unpartnered, user, vaporizing, vendor, verified

Removed: ADHD, Alberta, alleged, antihyperglycemia, AstraZeneca, batch, billion, bipolar, Broadfin, carvedilol, collectible, Complaint, confident, construction, consumed, Coreg, CR, crushed, depressive, deterrent, Effexor, employing, equipping, expended, forecast, fumarate, gastroesophageal, Glucophage, hypersecretory, hypertension, Identity, influenced, inhalation, Innovation, lawsuit, margin, metformin, mutually, nasal, pantoprazole, pathological, Pfizer, phosphate, powdered, predicted, problem, proceeded, Protonix, psychotropic, put, qualification, quetiapine, reflux, reimbursable, relation, renovation, reorganized, schizophrenia, secretion, Seroquel, sodium, Southern, stay, stipulated, syndrome, UK, unearned, venlafaxine, Wyeth, York

Intellipharmaceutics International (IPCIF) 20-F2013 FY Annual report (foreign)

Content analysis